Patents by Inventor Robert Benjamin Stein

Robert Benjamin Stein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Engineered host cells and methods of use thereof
    Patent number: 11898165
    Abstract: Provided herein are engineered host cells suitable for expression of functional T cell receptors (TCR) and methods of using these cells to identify TCRs that specifically bind to a desired peptide-major histocompatibility complex (MHC) complex.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: February 13, 2024
    Assignee: MiNK Therapeutics, Inc.
    Inventors: Marc Van Dijk, Volker Seibert, Robert Benjamin Stein
  • ENGINEERED HOST CELLS AND METHODS OF USE THEREOF
    Publication number: 20200263133
    Abstract: Provided herein are engineered host cells suitable for expression of functional T cell receptors (TCR) and methods of using these cells to identify TCRs that specifically bind to a desired peptide-major histocompatibility complex (MHC) complex.
    Type: Application
    Filed: September 9, 2016
    Publication date: August 20, 2020
    Inventors: Marc VAN DIJK, Volker SEIBERT, Robert Benjamin STEIN
  • VACCINES FOR TREATMENT AND PREVENTION OF CANCER
    Publication number: 20200237885
    Abstract: Provided are compositions useful as therapeutic vaccines (e.g., cancer vaccines), and methods of producing such compositions. The compositions disclosed herein generally employ a stress protein and at least one synthetic peptide, which may be a phosphopeptide or phosphopeptide mimetic, comprising a cancer-specific mutation present in a patient's cancer.
    Type: Application
    Filed: January 9, 2020
    Publication date: July 30, 2020
    Inventors: Daniel Lewis Levey, John Christopher Castle, Robert Benjamin Stein, Jennifer Shanda Buell
  • VACCINES FOR TREATMENT AND PREVENTION OF CANCER
    Publication number: 20160331821
    Abstract: Provided are compositions useful as therapeutic vaccines (e.g., cancer vaccines), and methods of producing such compositions. The compositions disclosed herein generally employ a stress protein and at least one synthetic peptide, which may be a phosphopeptide or phosphopeptide mimetic, comprising a cancer-specific mutation present in a patient's cancer.
    Type: Application
    Filed: May 13, 2016
    Publication date: November 17, 2016
    Inventors: Daniel Lewis Levey, John Christopher Castle, Robert Benjamin Stein, Jennifer Shanda Buell